Shepherd Kaplan Krochuk’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,362	Closed	-$135K	–	263
2018 Q1	$135K	Hold	10,362	–	–	0.08%	211
2017 Q4	$185K	Sell	10,362 -10,363	-50%	-$216K	0.11%	191
2017 Q3	$520K	Sell	20,725 -6,614	-24%	-$154K	0.43%	72
2017 Q2	$659K	Hold	27,339	–	–	0.38%	64
2017 Q1	$526K	Hold	27,339	–	–	0.27%	74
2016 Q4	$421K	Sell	27,339 -1,995	-7%	-$25.9K	0.12%	98
2016 Q3	$382K	Hold	29,334	–	–	0.08%	168
2016 Q2	$408K	Buy	+29,334	New	+$432K	0.1%	134
2014 Q4	–	Sell	-10,785	Closed	-$262K	–	567
2014 Q3	$262K	Buy	+10,785	New	+$282K	0.03%	380
2014 Q2	–	Sell	-2,583	Closed	-$95K	–	631
2014 Q1	$95K	Buy	+2,583	New	+$102K	0.01%	532

Other funds holding PRTK

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Shepherd Kaplan Krochuk's PRTK Position: Q2 2018 in Review

Shepherd Kaplan Krochuk sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2018, closing a stake of 10,362 shares — an estimated $135K sold.

Shepherd Kaplan Krochuk first reported a position in PRTK in Q1 2014 and held it in 10 quarters. The position peaked at $659K in Q2 2017. 110 funds tracked by Wall St. Rank hold PRTK as of Q2 2018.

Shepherd Kaplan Krochuk reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 10,362 Paratek Pharmaceuticals, Inc. shares in Q2 2018, an estimated $135K.
Shepherd Kaplan Krochuk first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2014 and held it in 10 quarters.
Shepherd Kaplan Krochuk's Paratek Pharmaceuticals, Inc. position peaked at $659K in Q2 2017.
110 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2018.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2018, filed 14 Aug 2018.